Recently, an anti-CD40 based vaccine against E7 was able to prime T cells to kill HPV-related tumor cells, suggesting that once cytotoxic T cells are primed against E7 targets, their killing may be optimized to achieve strong tumorcidal efficacy [17]. This evidence concerns the gene CD40 and neoplasm.